REN and Obesity: Furthermore, it is unclear whether a routine use of plasma renin activity assays whilst selecting the first line antihypertensive agents would add significantly to the BP control achieved compared with that achieved using simpler phenotypical correlates, such as race, age and possibly presence of obesity.